ATE195526T1 - Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin - Google Patents

Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin

Info

Publication number: ATE195526T1
Authority: AT; Austria
Prior art keywords: daunosamine; daunomycinone; daunorubicin; group; converted
Prior art date: 1996-12-16

Application number

AT96203554T

Other languages

English (en)

Inventor

Der Rijst Marcel Van

Johan Wilhelm Scheeren

Vos Dick De

Original Assignee

Pharmachemie Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-16

Filing date

1996-12-16

Publication date

2000-09-15

1996-12-16 Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv

2000-09-15 Application granted granted Critical

2000-09-15 Publication of ATE195526T1 publication Critical patent/ATE195526T1/de

Links

AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 title abstract 3
STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 title abstract 3
HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 title abstract 3
229960000975 daunorubicin Drugs 0.000 title abstract 3
STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 title abstract 3
229960001904 epirubicin Drugs 0.000 title abstract 3
150000003839 salts Chemical class 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
WPJRFCZKZXBUNI-HCWXCVPCSA-N daunosamine Chemical compound C[C@H](O)[C@@H](O)[C@@H](N)CC=O WPJRFCZKZXBUNI-HCWXCVPCSA-N 0.000 abstract 5
YOFDHOWPGULAQF-UHFFFAOYSA-N Daunomycin-Aglycone Natural products C1C(O)(C(C)=O)CC(O)C2=C1C(O)=C1C(=O)C(C=CC=C3OC)=C3C(=O)C1=C2O YOFDHOWPGULAQF-UHFFFAOYSA-N 0.000 abstract 4
LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 abstract 3
YOFDHOWPGULAQF-MQJDWESPSA-N (7s,9s)-9-acetyl-6,7,9,11-tetrahydroxy-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione Chemical compound C1[C@@](O)(C(C)=O)C[C@H](O)C2=C1C(O)=C1C(=O)C(C=CC=C3OC)=C3C(=O)C1=C2O YOFDHOWPGULAQF-MQJDWESPSA-N 0.000 abstract 2
TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 abstract 2
PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 abstract 2
230000008878 coupling Effects 0.000 abstract 2
238000010168 coupling process Methods 0.000 abstract 2
238000005859 coupling reaction Methods 0.000 abstract 2
PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
125000006239 protecting group Chemical group 0.000 abstract 2
238000006137 acetoxylation reaction Methods 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000003277 amino group Chemical group 0.000 abstract 1
230000031709 bromination Effects 0.000 abstract 1
238000005893 bromination reaction Methods 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
150000003840 hydrochlorides Chemical class 0.000 abstract 1
238000007086 side reaction Methods 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT96203554T 1996-12-16 1996-12-16 Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin ATE195526T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP96203554A EP0848009B1 (de)	1996-12-16	1996-12-16	Verfahren zur Herstellung von Epirubicin oder Zusatzsalzen davon, von Daunorubicin

Publications (1)

Publication Number	Publication Date
ATE195526T1 true ATE195526T1 (de)	2000-09-15

Family

ID=8224702

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96203554T ATE195526T1 (de)	1996-12-16	1996-12-16	Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin

Country Status (11)

Country	Link
US (1)	US5874550A (de)
EP (1)	EP0848009B1 (de)
JP (1)	JP4176845B2 (de)
AT (1)	ATE195526T1 (de)
CA (1)	CA2224764C (de)
DE (1)	DE69609845T2 (de)
DK (1)	DK0848009T3 (de)
ES (1)	ES2151632T3 (de)
GR (1)	GR3034608T3 (de)
PT (1)	PT848009E (de)
SI (1)	SI0848009T1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100785966B1 (ko) *	2000-08-10	2007-12-14	동아제약주식회사	안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
KR100850408B1 (ko) *	2000-08-10	2008-08-04	동아제약주식회사	안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
CN100412084C (zh) *	2003-07-02	2008-08-20	獀洛克斯股份有限公司	热稳定的结晶盐酸表柔比星及其制造方法
US20090099346A1 (en) *	2003-07-02	2009-04-16	Victor Matvienko	Thermally stable crystalline epirubicin hydrochloride
US7388083B2 (en) *	2005-03-07	2008-06-17	Solux Corporation	Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
WO2006111561A1 (en) *	2005-04-21	2006-10-26	Dsm Ip Assets B.V.	Improved microbial production of anthracyclins
RU2450013C2 (ru) *	2005-12-13	2012-05-10	Солюкс Корпорейшен	Способ получения 4-деметилдаунорубицина
US8802830B2 (en) *	2005-12-20	2014-08-12	Solux Corporation	Synthesis of epirubicin from 13-dihydrodaunorubicine
PL1990405T3 (pl) *	2007-05-08	2018-01-31	Provivo Oy	Genetycznie zmodyfikowane szczepy wytwarzające metabolity będące antracyklinami użyteczne jako leki przeciwnowotworowe
US8357785B2 (en) *	2008-01-08	2013-01-22	Solux Corporation	Method of aralkylation of 4′-hydroxyl group of anthracylins
AU2008361598B2 (en) *	2008-09-11	2015-02-12	Heraeus Precious Metals Gmbh & Co Kg	Genetically modified strains for biotransformations in anthracycline production
EP2636676A3 (de)	2009-09-08	2014-01-01	Heraeus Precious Metals GmbH & Co. KG	Kristallisierung von Epidaunorubicin x HCI
KR101125460B1 (ko)	2010-03-24	2012-03-28	동아제약주식회사	에피루비신 염산염의 신규한 결정형
DE102011103751A1 (de)	2011-05-31	2012-12-06	Heraeus Precious Metals Gmbh & Co. Kg	Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) *	2011-08-30	2013-02-28	Lead Discovery Center Gmbh	Neue Cyclosporin-Derivate
WO2015000132A1 (zh)	2013-07-02	2015-01-08	浙江海正药业股份有限公司	表阿霉素的制备方法及其中间体
WO2016159092A1 (ja)	2015-03-30	2016-10-06	ＭｅｉｊｉＳｅｉｋａファルマ株式会社	エピルビシンの製造方法およびその新規な製造中間体
CN104861014B (zh) *	2015-06-03	2017-09-29	道中道（菏泽）制药有限公司	一种盐酸表阿霉素结晶的制备方法
WO2017120729A1 (zh) *	2016-01-11	2017-07-20	浙江海正药业股份有限公司	一种盐酸表柔比星的制备方法及其中间体
CN112574267A (zh) *	2019-09-28	2021-03-30	鲁南制药集团股份有限公司	一种盐酸表柔比星中间体化合物iii
CN114149473B (zh) *	2020-09-08	2024-03-15	鲁南制药集团股份有限公司	一种盐酸表柔比星的合成方法及其中间体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3803124A (en)	1968-04-12	1974-04-09	Farmaceutici It Soc	Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives
GB1457632A (en)	1974-03-22	1976-12-08	Farmaceutici Italia	Adriamycins
JPS61502956A (ja)	1984-06-14	1986-12-18	ビオガル　ジヨジセルジヤ−ル	アドリアマイシン及びそのハロゲン化塩の調整法
GB8519452D0 (en) *	1985-08-02	1985-09-11	Erba Farmitalia	Injectable solutions
IT1196503B (it)	1986-07-16	1988-11-16	Erba Farmitalia	Procedimento continuo per la trasformazione di 4'-cheto-n-trifluoroacetildaunorubicina in 4'-epi-trifluoroacetildaunorubicina,internmedio per la preparazione di un composto
IT1230505B (it) *	1988-10-11	1991-10-25	Sicor Spa	Procedimento per la conversione della daunorubicina in doxorubicina.
IT1275953B1 (it) *	1995-03-22	1997-10-24	Sicor Spa	Procedimento per la preparazione di antibiotici della classe delle antracicline

1996
- 1996-12-16 DE DE69609845T patent/DE69609845T2/de not_active Expired - Fee Related
- 1996-12-16 ES ES96203554T patent/ES2151632T3/es not_active Expired - Lifetime
- 1996-12-16 DK DK96203554T patent/DK0848009T3/da active
- 1996-12-16 EP EP96203554A patent/EP0848009B1/de not_active Expired - Lifetime
- 1996-12-16 AT AT96203554T patent/ATE195526T1/de not_active IP Right Cessation
- 1996-12-16 PT PT96203554T patent/PT848009E/pt unknown
- 1996-12-16 SI SI9630241T patent/SI0848009T1/xx unknown
1997
- 1997-01-14 JP JP00494697A patent/JP4176845B2/ja not_active Expired - Fee Related
- 1997-12-04 US US08/985,358 patent/US5874550A/en not_active Expired - Fee Related
- 1997-12-15 CA CA002224764A patent/CA2224764C/en not_active Expired - Fee Related
2000
- 2000-10-12 GR GR20000402292T patent/GR3034608T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0848009B1 (de)	2000-08-16
CA2224764A1 (en)	1998-06-16
JPH10175991A (ja)	1998-06-30
ES2151632T3 (es)	2001-01-01
EP0848009A1 (de)	1998-06-17
CA2224764C (en)	2006-10-03
GR3034608T3 (en)	2001-01-31
PT848009E (pt)	2000-11-30
DE69609845T2 (de)	2000-12-21
DE69609845D1 (de)	2000-09-21
SI0848009T1 (en)	2000-12-31
DK0848009T3 (da)	2000-11-20
JP4176845B2 (ja)	2008-11-05
US5874550A (en)	1999-02-23

Legal Events

Date	Code	Title	Description
2000-12-15	UEP	Publication of translation of european patent specification
2009-09-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE195526T1 (de)	2000-09-15	Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin
DE69713374D1 (de)	2002-07-18	Verfahren zur herstellung von optisch reinen isomeren des formoterols
ES2061479T3 (es)	1994-12-16	Aminouretanos, procedimiento de obtencion y usos.
DE69020794D1 (de)	1995-08-17	Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
ATE48278T1 (de)	1989-12-15	Verfahren zur herstellung von 2'desoxyadenosinverbindungen.
JPS6410997A (en)	1989-01-13	Polysaccharide and production thereof
PT81528B (pt)	1987-12-30	Processo para a sintese de peptideos
ATE60308T1 (de)	1991-02-15	Verfahren zur herstellung fester aluminiumchlorid-zusammensetzungen.
ES2144698T3 (es)	2000-06-16	Procedimiento para preparar un derivado de biciclohexano.
DE69708420D1 (de)	2002-01-03	Herstellung von gereinigten (Poly)Peptiden
DK0524143T3 (da)	1998-08-24	Fremgangsmåde til fremstilling af aktiverede sialinsyrer
MX9207468A (es)	1993-06-01	Proceso para preparar acido 2,6-naftalenodicarboxilico purificado.
DE3751261D1 (de)	1995-05-24	Verfahren zur Herstellung eines Kohlensäureesters.
MA21305A1 (fr)	1988-12-31	Procede de preparation de l'acide (pyridyl-3)-3 ih,3h-pyrrono(i,2-c) thiazolecarboxylique-7 dextrocyre.
DE3750117D1 (de)	1994-07-28	Verfahren zur Herstellung von Indolinon-2-Derivaten.
DE59107545D1 (de)	1996-04-18	Salicylaldehyd- und Salicylsäurederivate sowie deren Schwefelanaloge, Verfahren und Zwischenprodukte zu ihrer Herstellung
ATE99323T1 (de)	1994-01-15	Verfahren zur wiedergewinnung eines gereinigten epi-proteins aus einer loesung, insbesondere einer gaerungsloesung.
ITMI911052A0 (it)	1991-04-16	Processo per la preparazione dell'acido 2,4 -diclorofenossiacetico
AU590659B2 (en)	1989-11-09	Process for producing l-amino acids or 5'-inosinic acid by fermentation
ATE93845T1 (de)	1993-09-15	Verfahren zur herstellung von 4,4'-bis-(4aminophenoxy)-diphenylsulfon.
DE69720432D1 (de)	2003-05-08	Verfahren zur herstellung von 2-hydroxynaphtalin-3,6-dicarbonsaure
ATE125526T1 (de)	1995-08-15	Verfahren zur herstellung von 2-chlor-4- fluorphenol.
DE69015797D1 (de)	1995-02-16	Verfahren zur herstellung von 3,4,3',4'-substituierten biphenylverbindungen.
ATE33384T1 (de)	1988-04-15	Verfahren zur herstellung eines 1,5-geschuetzten 1,5,10-triazadecans, zwischenprodukte hierfuer und deren herstellung.
BG51403A1 (en)	1993-05-14	Oligomer amonium salts of bromonitrosulphonic acids and method for their preparation